Chito-oligosaccharides and macrophages have synergistic effects on improving ovarian stem cells function by regulating inflammatory factors.


Journal

Journal of ovarian research
ISSN: 1757-2215
Titre abrégé: J Ovarian Res
Pays: England
ID NLM: 101474849

Informations de publication

Date de publication:
14 Apr 2023
Historique:
received: 30 10 2022
accepted: 19 03 2023
medline: 18 4 2023
entrez: 14 4 2023
pubmed: 15 4 2023
Statut: epublish

Résumé

Chronic low-grade inflammation and ovarian germline stem cells (OGSCs) aging are important reasons for the decline of ovarian reserve function, resulting in ovarian aging and infertility. Regulation of chronic inflammation is expected to promote the proliferation and differentiation of OGSCs, which will become a key means for maintaining and remodeling ovarian function. Our previous study demonstrated that Chitosan Oligosaccharides (Cos) promoted the OGSCs proliferation and remodelled the ovarian function through improving the secretion of immune related factors,but the mechanism remains unclear, and the role of macrophages, the important source of various inflammatory mediators in the ovary needs to be further studied. In this study, we used the method of macrophages and OGSCs co-culture to observe the effect and mechanism of Cos on OGSCs, and explore what contribution macrophages give during this process. Our finding provides new drug treatment options and methods for the prevention and treatment of premature ovarian failure and infertility. We used the method of macrophages and OGSCs co-culture to observe the effect and mechanism of Cos on OGSCs, and explore the important contribution of macrophages in it. The immunohistochemical staining was used to locate the OGSCs in the mouse ovary. Immunofluorescent staining, RT-qPCR and ALP staining were used to identify the OGSCs. CCK-8 and western blot were used to evaluate the OGSCs proliferation. β-galactosidase(SA-β-Gal) staining and western blot were used to detect the changing of cyclin-dependent kinase inhibitor 1A(P21), P53, Recombinant Sirtuin 1(SIRT1) and Recombinant Sirtuin 3(SIRT3). The levels of immune factors IL-2, IL-10, TNF-α and TGF-β were explored by using Western blot and ELISA. We found that Cos promoted OGSCs proliferation in a dose-and time-dependent manner, accompanied by IL-2, TNF-α increase and IL-10, TGF-β decrease. Mouse monocyte-macrophages Leukemia cells(RAW) can also produce the same effect as Cos. When combined with Cos, it can enhance the proliferative effect of Cos in OGSCs, and further increase IL-2, TNF-α and further decrease IL-10, TGF-β. The macrophages can enhance the proliferative effect of Cos in OGSCs is also associated with the further increase in IL-2, TNF-α and the further decrease in IL-10, TGF-β. In this study, we determined that the anti-aging genes SIRT-1 and SIRT-3 protein levels were increased by Cos and RAW respectively, whereas the senescence-associated SA-β-Gal and aging genes P21 and P53 were decreased. Cos and RAW had a protective effect on OGSCs delaying aging. Furthermore, RAW can further decrease the SA-β-Gal and aging genes P21 and P53 by Cos, and further increase SIRT1 and SIRT3 protein levels in OGSCs by Cos. In conclusion, Cos and macrophages have synergistic effects on improving OGSCs function and delaying ovarian aging by regulating inflammatory factors.

Sections du résumé

BACKGROUND BACKGROUND
Chronic low-grade inflammation and ovarian germline stem cells (OGSCs) aging are important reasons for the decline of ovarian reserve function, resulting in ovarian aging and infertility. Regulation of chronic inflammation is expected to promote the proliferation and differentiation of OGSCs, which will become a key means for maintaining and remodeling ovarian function. Our previous study demonstrated that Chitosan Oligosaccharides (Cos) promoted the OGSCs proliferation and remodelled the ovarian function through improving the secretion of immune related factors,but the mechanism remains unclear, and the role of macrophages, the important source of various inflammatory mediators in the ovary needs to be further studied. In this study, we used the method of macrophages and OGSCs co-culture to observe the effect and mechanism of Cos on OGSCs, and explore what contribution macrophages give during this process. Our finding provides new drug treatment options and methods for the prevention and treatment of premature ovarian failure and infertility.
METHODS METHODS
We used the method of macrophages and OGSCs co-culture to observe the effect and mechanism of Cos on OGSCs, and explore the important contribution of macrophages in it. The immunohistochemical staining was used to locate the OGSCs in the mouse ovary. Immunofluorescent staining, RT-qPCR and ALP staining were used to identify the OGSCs. CCK-8 and western blot were used to evaluate the OGSCs proliferation. β-galactosidase(SA-β-Gal) staining and western blot were used to detect the changing of cyclin-dependent kinase inhibitor 1A(P21), P53, Recombinant Sirtuin 1(SIRT1) and Recombinant Sirtuin 3(SIRT3). The levels of immune factors IL-2, IL-10, TNF-α and TGF-β were explored by using Western blot and ELISA.
RESULTS RESULTS
We found that Cos promoted OGSCs proliferation in a dose-and time-dependent manner, accompanied by IL-2, TNF-α increase and IL-10, TGF-β decrease. Mouse monocyte-macrophages Leukemia cells(RAW) can also produce the same effect as Cos. When combined with Cos, it can enhance the proliferative effect of Cos in OGSCs, and further increase IL-2, TNF-α and further decrease IL-10, TGF-β. The macrophages can enhance the proliferative effect of Cos in OGSCs is also associated with the further increase in IL-2, TNF-α and the further decrease in IL-10, TGF-β. In this study, we determined that the anti-aging genes SIRT-1 and SIRT-3 protein levels were increased by Cos and RAW respectively, whereas the senescence-associated SA-β-Gal and aging genes P21 and P53 were decreased. Cos and RAW had a protective effect on OGSCs delaying aging. Furthermore, RAW can further decrease the SA-β-Gal and aging genes P21 and P53 by Cos, and further increase SIRT1 and SIRT3 protein levels in OGSCs by Cos.
CONCLUSION CONCLUSIONS
In conclusion, Cos and macrophages have synergistic effects on improving OGSCs function and delaying ovarian aging by regulating inflammatory factors.

Identifiants

pubmed: 37060101
doi: 10.1186/s13048-023-01143-z
pii: 10.1186/s13048-023-01143-z
pmc: PMC10103396
doi:

Substances chimiques

Interleukin-10 130068-27-8
Sirtuin 1 EC 3.5.1.-
Tumor Necrosis Factor-alpha 0
Tumor Suppressor Protein p53 0
Interleukin-2 0
Sirtuin 3 EC 3.5.1.-
Transforming Growth Factor beta 0
Oligosaccharides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76

Subventions

Organisme : Natural Science Foundation of Jiangxi Province
ID : No.20181ACB20018
Organisme : Basic Research Scheme of Shenzhen Science and Technology Innovation Commission
ID : JCYJ20190812161405275
Organisme : National Natural Science Foundation of China
ID : No. 81671455

Informations de copyright

© 2023. The Author(s).

Références

Reprod Fertil Dev. 2015 Jul;27(6):969-74
pubmed: 25897831
Reproduction. 2020 Mar;159(3):325-337
pubmed: 31940276
Hum Reprod Update. 2004 Mar-Apr;10(2):119-33
pubmed: 15073142
Biomaterials. 2021 Dec;279:121213
pubmed: 34715637
Stem Cells Int. 2014;2014:720753
pubmed: 25548574
Cell Tissue Res. 2021 Oct;386(1):145-156
pubmed: 34415395
Hum Reprod Update. 2016 Nov;22(6):725-743
pubmed: 27562289
Stem Cell Res Ther. 2014 Aug 18;5(4):98
pubmed: 25157949
Aging Cell. 2017 Oct;16(5):976-987
pubmed: 28681509
J Ovarian Res. 2022 Jul 4;15(1):79
pubmed: 35787298
Arch Toxicol. 2018 Apr;92(4):1581-1591
pubmed: 29380011
Reproduction. 2019 Sep;158(3):R79-R90
pubmed: 30999278
Nature. 2004 Mar 11;428(6979):145-50
pubmed: 15014492
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33523841
Am J Reprod Immunol. 2020 Aug;84(2):e13265
pubmed: 32395847
Reprod Sci. 2015 Jul;22(7):884-903
pubmed: 25779995
Prog Mol Subcell Biol. 2007;45:179-204
pubmed: 17585501
Chin J Nat Med. 2021 Oct;19(10):721-731
pubmed: 34688462
Nat Rev Immunol. 2019 May;19(5):291-304
pubmed: 30679807
Anat Rec (Hoboken). 2011 Aug;294(8):1284-306
pubmed: 21714105
Aging (Albany NY). 2016 Oct 7;8(10):2392-2406
pubmed: 27750221
In Vitro Cell Dev Biol Anim. 2020 Jan;56(1):59-66
pubmed: 31900800
Development. 2016 Jan 1;143(1):3-14
pubmed: 26732838
Birth Defects Res C Embryo Today. 2009 Mar;87(1):64-89
pubmed: 19306350
Hum Reprod. 2018 May 1;33(5):887-894
pubmed: 29481647
Cell Physiol Biochem. 2017;41(3):1051-1062
pubmed: 28245464
Expert Opin Biol Ther. 2012 Jun;12(6):673-84
pubmed: 22500889
J Ovarian Res. 2018 Jan 5;11(1):3
pubmed: 29304868
J Ovarian Res. 2022 Mar 23;15(1):37
pubmed: 35321734
Pharmacol Ther. 2017 Feb;170:80-97
pubmed: 27773783
Aging (Albany NY). 2019 Feb 14;11(3):1030-1044
pubmed: 30779707
Gene. 2016 Jan 10;575(2 Pt 3):680-6
pubmed: 26403315
Stem Cells. 2020 Sep;38(9):1060-1077
pubmed: 32473067
Stem Cells Dev. 2021 Aug 1;30(15):749-757
pubmed: 34036812
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E91-E101
pubmed: 32343612
Science. 2013 Feb 15;339(6121):749
pubmed: 23413331
Reprod Biol Endocrinol. 2012 Dec 17;10:112
pubmed: 23245287
Cell Physiol Biochem. 2015;37(6):2311-22
pubmed: 26645720
Immunity. 2013 Mar 21;38(3):570-80
pubmed: 23434060
Exp Ther Med. 2018 Nov;16(5):3965-3972
pubmed: 30402146
Reprod Biol Endocrinol. 2014 Nov 24;12:113
pubmed: 25421381
Int J Fertil Steril. 2016 Jan-Mar;9(4):411-5
pubmed: 26985328
Hum Immunol. 2015 May;76(5):385-91
pubmed: 25305457
Biol Reprod. 2021 Jul 2;105(1):100-112
pubmed: 33709094
J Immunol Res. 2019 Jan 2;2019:8069898
pubmed: 30719458
Mol Ther. 2017 Jun 7;25(6):1408-1419
pubmed: 28528817
Front Cell Dev Biol. 2021 Feb 11;8:628473
pubmed: 33644037
PLoS One. 2012;7(4):e35535
pubmed: 22536401
Syst Biol Reprod Med. 2019 Apr;65(2):121-128
pubmed: 30204491
Nat Commun. 2020 Nov 6;11(1):5628
pubmed: 33159074
J Assist Reprod Genet. 2018 Oct;35(10):1831-1841
pubmed: 30043336
Reprod Biol Endocrinol. 2012 Nov 23;10:97
pubmed: 23176151
Nat Cell Biol. 2009 May;11(5):631-6
pubmed: 19363485
Biol Reprod. 2021 Mar 11;104(3):527-538
pubmed: 33274732
Annu Rev Immunol. 2013;31:317-43
pubmed: 23298208
Oxid Med Cell Longev. 2022 Apr 1;2022:4247042
pubmed: 35401926
Anal Cell Pathol (Amst). 2018 Mar 15;2018:1289103
pubmed: 29736365
Front Cell Dev Biol. 2019 Oct 30;7:256
pubmed: 31750302

Auteurs

K Zheng (K)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China.

Wenli Hong (W)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China.
Shenzhen University Health Science Center, Shenzhen, China.

Haifeng Ye (H)

Institute of Regenerative Biology and Medicine, Helmholtz Zentrum München, München, Germany.

Ziqiong Zhou (Z)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China.

Shuyi Ling (S)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China.

Yuan Li (Y)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China.

Yuqing Dai (Y)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China.

Zhisheng Zhong (Z)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China.

Ziwei Yang (Z)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China. 547933119@qq.com.

Yuehui Zheng (Y)

Reproductive Health Department, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, China. yuehuizheng@163.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH